KA

Khwairakpam Apanthou Mangang

Active Director Director DIN 09388659
DIN 09388659 First appointment Nov 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Khwairakpam Apanthou Mangang

Data last updated:

Khwairakpam Apanthou Mangang is a Director at Mase Therapeutics Private Limited (since 2021). The company operates in Chemicals.

DIN 09388659
Primary Designation Director
Industry Chemicals
First Appointment 05 Nov 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mase Therapeutics Private Limited U24299MN2021PTC014430
Director05 Nov 20212021Active

Board colleagues of Khwairakpam Apanthou Mangang

NameDINCompanyDesignation
Mangangkhomba Khwairakpamcha09388658Mase Therapeutics Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mase Therapeutics Private Limited
Premium access

Shareholding and investment profile for Khwairakpam Apanthou Mangang

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Khwairakpam Apanthou Mangang

Khwairakpam Apanthou Mangang currently holds 1 directorship: Mase Therapeutics Private Limited (Director, since 05 Nov 2021).

Khwairakpam Apanthou Mangang was first appointed on 05 Nov 2021 as Director at Mase Therapeutics Private Limited.

The current boards of Khwairakpam Apanthou Mangang's companies include Mangangkhomba Khwairakpamcha (Mase Therapeutics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available